Coronary artery disease. Drug-eluting stents or CABG?

Comment

João H Duarte. Nat Rev Cardiol. 2015 May.

. 2015 May;12(5):259.

doi: 10.1038/nrcardio.2015.48. Epub 2015 Mar 31.

No abstract available

Comment on

Trial of everolimus-eluting stents or bypass surgery for coronary disease.
Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Choo SJ, Chung CH, Lee JW, Cohen DJ, Yeung AC, Hur SH, Seung KB, Ahn TH, Kwon HM, Lim DS, Rha SW, Jeong MH, Lee BK, Tresukosol D, Fu GS, Ong TK; BEST Trial Investigators. Park SJ, et al. N Engl J Med. 2015 Mar 26;372(13):1204-12. doi: 10.1056/NEJMoa1415447. Epub 2015 Mar 16. N Engl J Med. 2015. PMID: 25774645 Clinical Trial.
Randomized Trial of Stents Versus Bypass Surgery for Left Main Coronary Artery Disease: 5-Year Outcomes of the PRECOMBAT Study.
Ahn JM, Roh JH, Kim YH, Park DW, Yun SC, Lee PH, Chang M, Park HW, Lee SW, Lee CW, Park SW, Choo SJ, Chung C, Lee J, Lim DS, Rha SW, Lee SG, Gwon HC, Kim HS, Chae IH, Jang Y, Jeong MH, Tahk SJ, Seung KB, Park SJ. Ahn JM, et al. J Am Coll Cardiol. 2015 May 26;65(20):2198-206. doi: 10.1016/j.jacc.2015.03.033. Epub 2015 Mar 15. J Am Coll Cardiol. 2015. PMID: 25787197 Clinical Trial.